Intravenous vinorelbine (NVBiv) on D1 and oral vinorelbine (NVBo) on D8 in combination with carboplatin (CBDCA) as first line treatment in advanced non-small lung cancer (NSCLC) patients: preliminary results of a prospective study

• Authors: SKŘIČKOVÁ Jana; KEILOVÁ Jana; JANÁSKOVÁ Tereza; KOLEK Vítězslav; CHALUPA Jiří; ROUBEC Jaromír; TŘASOŇ Tomáš; TOMÍŠKOVÁ Marcela; KADLEC Bohdan; ŠVECOVÁ Jiřina; GRYGÁRKOVÁ Ivona; KOHOUTEK Milan
• Year of publication: 2009
• Type: Article in Periodical
• Magazine / Source: Journal of Thoracic Oncology
• MU Faculty or unit: Faculty of Medicine
• Field: Pneumology
• Keywords: Vinorelbine intravenous and oral; carboplatin; first line treatment in advanced non-small lung cancer (NSCLC) patients; preliminary results of a prospective study
• Description: Preliminary results are presented of a prospective trial of intravenous vinorelbine (NVBiv) on D1 and oral vinorelbine (NVBo) on D8 in combination with carboplatin (CBDCA) as first line treatment in patients with advanced non-small lung cancer (NSCLC) patients: preliminary results of a prospective study

Related projects

• Environment - carcinogenesis - oncology